NASDAQ: ADMA · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

ADMA Biologics Inc

How ADMA Biologics Inc compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.6B

Price

$11.75

P/E

15.7

EPS (TTM)

$0.75

1-year return

-24.3%

Dividend yield

0.0%

52-week range

$9.72–$16.36

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources